• News

The immune system strikes back

Copenhagen, Denmark – November 9, 2016:  Professor Mads Hald Andersen, CSO of IO Biotech and Director of CCIT (Center for Cancer Immune Therapy) at University of Copenhagen Herlev Hospital in Denmark, will be speaking at the SITC Conference in Maryland this week.

Continue Reading

IO Biotech appoints Dr Peter Hirth as Chairman of the Board

Copenhagen, Denmark – October 4, 2016: IO Biotech today announced that industry veteran Dr Peter Hirth will succeed Dr Hans Schambye as Chairman of the Board of Directors. IO Biotech develops novel therapeutic immuno-oncology vaccines targeting immune check point inhibitory targets to treat cancer.

Continue Reading